Eduardo Molina

Eduardo joined Ipsen in September 2024, bringing both U.S. and global experience with deep strategic and operational understanding in hematology/oncology and rare disease launches.

In Eduardo’s role, he will be responsible for leading our Business Operations team to support our growing and evolving U.S. business. In addition, he will serve as Chief of Staff to the President of North America.

Eduardo joined Ipsen from bluebird bio where he served as VP, Marketing, Strategy and Analytics, leading the marketing strategy and execution for gene therapy launches in hematology/rare diseases. Prior to that, he served as Head of U.S. Marketing for Reblozyl for Merck/Acceleron and as the global commercial team leader for Venclexta at Abbvie, both during their critical U.S. launch period. Eduardo also spent a number of years during his career at Novartis Oncology, working in a variety of U.S., Global and Regional roles of increasing responsibility across sales, marketing and strategy.

Eduardo received his MBA from The Wharton School and Masters of International Studies from the Lauder Institute at the University of Pennsylvania.